INTERLEUKIN-2 FOR USE IN TREATING AUTISM SPECTRUM DISORDER
Application
US20260092095A1
Kind: A1
Apr 02, 2026
Assignee
INSERM (INSTITUT NATIONAL DE LA SANTÉ ET LA RECHERCHE MÉDICALE)
Inventors
David Klaatzman, Pierre Ellul, Michelle Rosenzwajg, Richard Delorme, Gwladys Fourcade
Abstract
The invention relates to the use of IL-2 in treating autism spectrum disorder (ASD) in a subject, as well as in preventing ASD in children, by administering the IL-2 to a child at risk of ASD or to a pregnant mother at risk of having a child with ASD.
CPC Classifications
C07K 14/55
A61K 38/00
Filing Date
2022-09-12
Application No.
19110627